NAACCR Item #3852: HER2 ISH Dual Probe Ratio
Padding Character' '
|Item #||Length||Source of Standard||Year Implemented||Version Implemented||Year Retired||Version Retired||Column #|
|3852||4||NAACCR||2018||18||1762 - 1765|
NAACCR XML: Tumor.her2IshDualProbeRatio
HER2 in situ hybridization (ISH) Dual Probe Ratio is the summary score for HER2 testing using a dual probe. The test will report results for both HER2 and CEP17, the latter used as a control. The HER2/CEP17 ratio is reported.
HER2 ISH Dual Probe Ratio is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+.
|0.0-99.9||Ratio of 0.0 to 99.9|
|XX.2||Less than 2.0|
|XX.3||Greater than or equal to 2.0|
|XX.7||Test ordered, results not in chart|
|XX.8||Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of code XX.8 will result in an edit error.)
|XX.9||Not documented in medical record
Results cannot be determined (indeterminate)
HER2 ISH Dual Probe Ratio not assessed or unknown if assessed
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.